skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.06d (Release date: 2017-06-26)
SearchBox Top
SearchBox Bottom
VEGFR2-targeted Contrast Agent BR55 (Code C95204)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: VEGFR2-targeted Contrast Agent BR55

Definition: A lipopeptide-based, vascular endothelial growth factor receptor 2 (VEGRF2) -targeted contrast agent with the property of molecular imaging of angiogenesis. BR55 is prepared by incorporation of a biospecific heterodimer peptide into the perfluorobutane-containing lipid-shelled microbubble membrane; the peptide specifically binds to VEGFR2 expressed on tumoral vascular endothelium allowing ultrasound imaging of the sites of active angiogenesis.

Label: VEGFR2-targeted Contrast Agent BR55

NCI Thesaurus Code: C95204 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: CL426694  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
VEGFR2-targeted Contrast Agent BR55

External Source Codes: 
PDQ Closed Trial Search ID 690943
PDQ Open Trial Search ID 690943 (check for NCI PDQ open clinical trial info)

Other Properties:
     Name Value (qualifiers indented underneath)
code C95204
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom